|
|
|
|
|
|
|
| |
|
|
|
|
Funding
Agency |
Title
of Project or Program |
Principal
Investigator(s) |
Project
Period |
Total
Costs |
|
Potential Role of Fetal
Stem Cells in Lung Tumor Development |
J. Sawicki |
3/08 - 2/10 |
$402,701 |
|
Targeting Nanoparticle
DNA Delivery to Ovarian Cancer |
J. Sawicki |
2/08 - 1/13 |
$1,303,551 |
|
Directing the Fate of
Cells to Myogenic Lineages |
M. George-Weinstein |
2/08 - 1/11 |
$973,936 |
|
Human Monoclonal Antibodies
that Bind Otulinum Toxins |
S. Dessain |
12/07 - 1/11 |
$1,365,604 |
|
Targeting Nanoparticle
DNA Delivery to Prostate Tumors |
J. Sawicki |
6/07 - 3/11 |
$1,294,786 |
|
Regulation of Calcium
Channel Expression in Hypertension by Truncated Subunits |
R. Cox |
1/07 - 12/09 |
$295,000 |
|
Polyamines and epithelial
tumorigenesis |
S. Gilmour |
12/06 to 11/11 |
$1,613,942 |
|
Oxidative Pentose Cycle
in Hypoxic Cancer Cell Response |
I. Ayene |
11/06 to 3/09 |
$778,900 |
|
Primordial germ cell tumor susceptinility at the PGCT1 locus |
A. Muller |
1/06 to 12/08 |
$247,500 |
|
RhoB-directed SMC growth
and atherosclerotic lesion formation |
L. Laury-Kleintop &
G.Prendergast |
2/06-1/09 |
$295,000 |
|
|
|
|
 |
|
 |